MNPR Stock Analysis: Buy, Sell, or Hold?
MNPR - Monopar Therapeutics Inc. Common Stock
$87.68
0.05 (0.06%)
▲
5d:
+29.95%
30d:
+35.83%
90d:
+60.7%
WAIT
LOW Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When MNPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: MNPR is 16.1% above its trading range ($75.52). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: MNPR is 16.1% above its trading range ($75.52). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: MNPR is currently trading at $87.68, which is considered extended relative to its 30-day fair value range of $57.10 to $75.52.
Technical Outlook: Technically, MNPR is in a uptrend. Immediate support is located at $59.06, while resistance sits at $94.83.
Market Sentiment: MNPR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $112.62 (+28.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MNPR is in a uptrend. Immediate support is located at $59.06, while resistance sits at $94.83.
Market Sentiment: MNPR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $112.62 (+28.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$57.10 -
$75.52
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+16.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 28.4% below Wall St target ($112.62)
- WARNING: Recommendation downgraded due to 16.1% overvaluation
Trading Range Analysis
30-Day Trading Range
$57.10 -
$75.52
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$59.06
Resistance Level
$94.83
Current Trend
Uptrend
Technical data as of
Jun 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-27.71
Wall Street Target
$112.62
(+28.4%)
Share & Embed Analysis
Last updated: June 29, 2026 4:30 AM ET
Data refreshes hourly during market hours. Next update: 5:30 AM
Data refreshes hourly during market hours. Next update: 5:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 65 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 60 BUY |
